J. Safra Sarasin Holding Ag Xenon Pharmaceuticals Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.52 Trillion
- Q1 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 30,573 shares of XENE stock, worth $962,743. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,573
Previous 17,786
71.89%
Holding current value
$962,743
Previous $697 Million
47.12%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$181 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$144 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$119 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$105 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$97.3 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.96B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...